Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalThe AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblastsIdentification of yeast and human 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAr) transportersArtemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesDose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer CellsMetformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent BiosynthesisMetformin as a cellular protector; a synoptic view of modern evidencesSerine hydroxymethyltransferase: a key player connecting purine, folate and methionine metabolism in Saccharomyces cerevisiae.Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.Dissecting the role of AMP-activated protein kinase in human diseases.Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.microRNAs and cancer metabolism reprogramming: the paradigm of metforminMetformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectivesMaternal-fetal nutrient transport in pregnancy pathologies: the role of the placentaDrugs acting on homeostasis: challenging cancer cell adaptation.Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium.Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.Deregulated proliferation and differentiation in brain tumors.Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMetformin use and lung cancer risk in patients with diabetes.2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseGlucose-based regulation of miR-451/AMPK signaling depends on the OCT1 transcription factor.AMP-Activated Protein Kinase Regulates the Cell Surface Proteome and Integrin Membrane Traffic.Impact of AMP-Activated Protein Kinase α1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction.Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?The double trouble of metabolic diseases: the diabetes-cancer link.Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary TumorigenesisDisruption of Nucleotide Homeostasis by the Antiproliferative Drug 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Monophosphate (AICAR).The new biology of diabetes.AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells.Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agentsIntact LKB1 activity is required for survival of dormant ovarian cancer spheroidseIF3 controls cell size independently of S6K1-activity.Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
P2860
Q26744536-BB09697E-97AB-4218-ADE7-A6319F3E941FQ27312584-EE2BB00B-98D4-4BF4-936E-6CA718E71756Q27938996-64FC85FE-AEE5-42D3-8772-63735CC16764Q28066236-D9BCADBA-4F81-41AE-A4C1-E9B0D869D172Q28081491-5ABF6678-086E-413F-9F60-C8835774550BQ28542653-E220C7FF-E033-4E20-B535-1A5BCEEACD6BQ28551227-C3EECAA4-F035-40A6-9B97-554E88EF5A73Q28817196-E73A74A2-42E2-404F-8E0C-4EDC6DDD87B1Q30316637-15EC9119-1290-491A-94DD-8A11A704EB4FQ30353578-35E86592-31DD-4B8C-AC33-B86AE310253EQ30395557-05E18DC8-37CD-4CA6-8737-771CE118A53CQ33682914-DA28FFF6-68D7-444D-A1D4-BE169A3E0349Q34042731-BF282209-6CCD-4B59-9B0B-3199FFF208E1Q34357915-8B0D7DFA-25E7-4696-930B-5F23EB61C150Q34357944-CDBB489E-1470-4DE1-B956-2FE0033445D7Q34358511-D97046B1-D8B7-47C4-B3D8-F03CF0CD52A5Q34500113-338DAE73-D188-4522-887B-5063ABAA0CF3Q34505650-C7F60D65-EAD3-4E7D-85AF-4F0DD7EF454EQ34506762-8D2D2AB4-44B7-4125-80A9-5A66E8D10128Q34859989-5EDF0DFE-6741-4262-87AD-5E95502953F2Q34957038-860A85E2-196B-4788-8876-17E6D2B585DFQ34957274-3C771CCF-B3D7-4E38-94B7-E57020A10DFAQ35046673-7B7A8FDD-B188-42A5-AC49-3AC9F24B1E7CQ35289357-6C233A91-D337-41C4-B2DE-4B68E802AEEFQ35600122-647EEE0A-CE2B-4FCC-AA1C-DEA6731F1013Q35607018-4246BF2C-2680-415E-9692-BFF546F3CE03Q35641071-E065800E-3ED7-4B86-A72C-38A77AE02A61Q35748914-E77A3B44-1842-4BC9-80AC-3F37C6DA42FBQ35813290-3220E74E-94B1-4D08-BEFC-27283AEBC520Q36058422-8FAB2970-8F42-42E4-A8FF-7A6BCE88E0DDQ36078840-CC7C9A68-9B8B-4914-8DDD-A24F77E4B4C3Q36092969-C3F4CA67-D49C-4D45-8F7C-73D6E087517FQ36113537-12986CFE-1BD8-4C73-A56C-A730065C94EDQ36174103-24B9838B-EC9D-4B7B-AD3F-CC50D5417372Q36182575-73B08231-B9A3-4187-9C68-ADFCE20B0E9EQ36305220-6FA4AD8C-4151-42F9-907C-13E931684B74Q36349917-51610EFA-9AD4-449E-8109-0760DAC11A10Q36355979-24153F0B-8967-4CA9-AD97-8444F955438EQ36414466-23E3C52B-31B1-4021-9ECF-F46390CCE57CQ36545028-2B199E75-395D-45F9-A5B6-D01FF0275CA3
P2860
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discrete mechanisms of mTOR an ...... agonists independent of AMPK.
@en
Discrete mechanisms of mTOR an ...... agonists independent of AMPK.
@nl
type
label
Discrete mechanisms of mTOR an ...... agonists independent of AMPK.
@en
Discrete mechanisms of mTOR an ...... agonists independent of AMPK.
@nl
prefLabel
Discrete mechanisms of mTOR an ...... agonists independent of AMPK.
@en
Discrete mechanisms of mTOR an ...... agonists independent of AMPK.
@nl
P2093
P2860
P50
P356
P1476
Discrete mechanisms of mTOR an ...... K agonists independent of AMPK
@en
P2093
Ady Kendler
Ashish Kumar
Biplab Dasgupta
Brian Quinn
Christopher McPherson
Gregory A Grabowski
Jeroen Poels
Rishi Raj Chhipa
Ronald E Warnick
Sara Yachyshin
P2860
P304
P356
10.1073/PNAS.1311121111
P407
P577
2014-01-13T00:00:00Z